Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Change in Accured Expenses (2019 - 2025)

Historic Change in Accured Expenses for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $7.5 million.

  • Strata Critical Medical's Change in Accured Expenses rose 102244.14% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 34882.89%. This contributed to the annual value of -$8.3 million for FY2024, which is 19214.28% down from last year.
  • According to the latest figures from Q3 2025, Strata Critical Medical's Change in Accured Expenses is $7.5 million, which was up 102244.14% from $3.2 million recorded in Q2 2025.
  • Strata Critical Medical's Change in Accured Expenses' 5-year high stood at $7.5 million during Q3 2025, with a 5-year trough of -$10.2 million in Q1 2024.
  • Its 5-year average for Change in Accured Expenses is $1.4 million, with a median of $2.2 million in 2021.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 669235.84% in 2021, then tumbled by 22833.84% in 2023.
  • Over the past 5 years, Strata Critical Medical's Change in Accured Expenses (Quarter) stood at $1.9 million in 2021, then surged by 193.4% to $5.6 million in 2022, then fell by 12.08% to $5.0 million in 2023, then tumbled by 100.04% to -$2000.0 in 2024, then skyrocketed by 374150.0% to $7.5 million in 2025.
  • Its Change in Accured Expenses stands at $7.5 million for Q3 2025, versus $3.2 million for Q2 2025 and -$2.3 million for Q1 2025.